ARAY - ACCURAY INC


1.62
0.010   0.617%

Share volume: 405,212
Last Updated: 04-29-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: 0.00%

PREVIOUS CLOSE
CHG
CHG%

$1.61
0.01
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
54%
Profitability 48%
Dept financing 43%
Liquidity 20%
Performance 70%
Company vs Stock growth
vs
Performance
5 Days
2.53%
1 Month
-9.50%
3 Months
-30.17%
6 Months
-13.83%
1 Year
-23.94%
2 Year
-53.18%
Key data
Stock price
$1.62
P/E Ratio 
0.00
DAY RANGE
$1.58 - $1.64
EPS 
-$0.10
52 WEEK RANGE
$1.40 - $2.95
52 WEEK CHANGE
-$25.35
MARKET CAP 
199.119 M
YIELD 
N/A
SHARES OUTSTANDING 
99.244 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-30-2025
BETA 
3.18
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$400,204
AVERAGE 30 VOLUME 
$603,583
Company detail
CEO: Suzanne C. Winter
Region: US
Website: accuray.com
Employees: 1,040
IPO year: 2007
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. The company also provides the TomoTherapy System, including the Radixact System.

Recent news
loading